Axiom Bio · Seed

AI models that predict human drug toxicity without animal testing

Amount

$15M

Round

Seed

Valuation

—

Announced

Apr 2025

Investors

Lead investor

Amplify Partners

Participating investors

Zetta Venture Partners Jeff Dean Dimension Capital Laksh Aithani Barry McCardel Alec Nielsen Ari Morcos Stef van Grieken Elliot Hershberg